Search results
Your query:
Sysno = ("0181298" OR "0181297" OR "0181306" OR "0181308" OR "0181312" OR "0181313" OR "0181311" OR "0181316" OR "0181310" OR "0181307" OR "0181294" OR "0181305" OR "0181320" OR "0181296" OR "0181309" OR "0181293" OR "0181295" OR "0181301" OR "0181315" OR "0181302" OR "0181299")
- Adjuvantná liečba melanómu v 3. štádiu po kompletnej resekcii / Silvia Jurišová . Onkológia. - ISSN 1336-8176 . - Roč. 17, č. 2 (2022), s. 108-111 : ilustr., fareb., grafy, tab.
- C 3069
- Ako sa pozeráme na inhibítory CDK4/6 v paliatívnej liečbe dnes / Miroslava Malejčíková . Onkológia. - ISSN 1336-8176 . - Roč. 17, č. 2 (2022), s. 102-107 : ilustr., fareb., sch., tab.
- C 3069
- ASCO Gastrointestinal Cancers 2022 / Tomáš Šálek . Onkológia. - ISSN 1336-8176 . - Roč. 17, č. 2 (2022), s. 135-137 : ilustr., fareb., fotogr.
- C 3069
- Comprehensive Assessment of Selected Immune Cell Subpopulations Changes in Chemotherapy-Naïve Germ Cell Tumor Patients / Kalavska K. ... [et al.] . Onkológia. - ISSN 1336-8176 . - Roč. 17, č. 2 (2022), s. 138
- C 3069
- Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with Pseudomonas aeruginosa Pneumonia / Drgona L. ... [et al.] . Onkológia. - ISSN 1336-8176 . - Roč. 17, č. 2 (2022), s. 139-140
- C 3069
- Effective Reduction of SARS-CoV-2 RNA Levels Using a Tailor-Made Oligonucleotide-Based RNA Inhibitor / Drgona L. ... [et al.] . Onkológia. - ISSN 1336-8176 . - Roč. 17, č. 2 (2022), s. 140
- C 3069
- Effectiveness, Adverse Events, and Immune Response Following Double Vaccination with BNT162b2 in Staff at the National Comprehensive Cancer Center (NCCC) / Palacka P. ... [et al.] . Onkológia. - ISSN 1336-8176 . - Roč. 17, č. 2 (2022), s. 139
- C 3069
- Establishment of a virtual transborder tumor board for cancer patients in Central and Southeastern Europe : An initiative of the Central European Cooperative Oncology Group (CECOG) / Berzinec P. ... [et al.] . Onkológia. - ISSN 1336-8176 . - Roč. 17, č. 2 (2022), s. 140-141
- C 3069
- Evaluating Alternative Ramucirumab Doses as a Single Agent or with Paclitaxel in Second-Line Treatment of Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma: Results from Two Randomized, Open-Label, Phase II Studies / Salek T. ... [et al.] . Onkológia. - ISSN 1336-8176 . - Roč. 17, č. 2 (2022), s. 139
- C 3069
- Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor Outcome in Male Malignant Germ Cell Tumors / Schmidtova S. ... [et al.] . Onkológia. - ISSN 1336-8176 . - Roč. 17, č. 2 (2022), s. 138
- C 3069